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Context. Measuring What Matters (MWM) for palliative care has prioritized data collection efforts for evaluating quality in
clinical practice. How these measures can be implemented across diverse clinical settings using point-of-care data collection
on quality is unknown.
Objectives. To evaluate the implementation of MWMmeasures by exploring documentation of quality measure adherence
across six diverse clinical settings inherent to palliative care practice.
Methods. We deployed a point-of-care quality data collection system, the Quality Data Collection Tool, across five
organizations within the Palliative Care Research Cooperative Group. Quality measures were recorded by clinicians or
assistants near care delivery.
Results. During the study period, 1989 first visits were included for analysis. Our population was mostly white, female, and
with moderate performance status. About half of consultations were seen on hospital general floors. We observed a wide range
of adherence. The lowest adherence involved comprehensive assessments during the first visit in hospitalized patients in the
intensive care unit (2.71%); the highest adherence across all settings, with an implementation of >95%, involved
documentation of management of moderate/severe pain. We observed differences in adherence across clinical settings
especially with MWM Measure #2 (Screening for Physical Symptoms, range 45.7%e81.8%); MWM Measure #5 (Discussion of
Emotional Needs, range 46.1%e96.1%); and MWM Measure #6 (Documentation of Spiritual/Religious Concerns, range
0e69.6%).
Conclusion. Variations in clinician documentation of adherence to MWM quality measures are seen across clinical settings.
Additional studies are needed to better understand benchmarks and acceptable ranges for adherence tailored to various
clinical settings. J Pain Symptom Manage 2016;51:497e503.  2016 American Academy of Hospice and Palliative Medicine.
Published by Elsevier Inc. All rights reserved.
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itizedmeasures for thefield. The goal ofMeasuringWhat
Matters (MWM)4 was to provide the field of hospice
and palliative medicine with a select set of valid and
implementable quality indicators to measure quality
of care. Such a select set is expected to support regular
quality assessment and measurement within individual
palliative care organizations. Data from these efforts
have the potential to inform establishment of bench-
marks and collaborative quality improvement efforts.
As the MWM initiative proposed a list of 10 quality
measures, significant unanswered questions remain.
First, how do these measures perform in the diverse
settings and patient populations for whom palliative
care is appropriate? Second, how does adherence to
these measures compare across these settings? These
remain unanswered questions for a few key reasons.
One reason is that the MWM measures were only
recently defined; experiences with integrating these
measures are relatively recent. Additionally, each
component measure of MWM was tested and validated
in a patient population defined by a specific diagnosis
or setting using retrospective chart abstraction. For
example, MWM Measure #9 (Care Consistency with
Documented Care Preferences) was developed for
and tested within a hospitalized patient population.5
We do not yet know how clinicians will use these mea-
sures in other settings, like outpatient clinics. Another
example is MWM Measure #1, which recommends a
‘‘comprehensive assessment’’ for all patients evaluated
by the team. This measure was included from the set
of ‘‘Prepare, Embrace, Attend, Communicate,
Empower’’ (PEACE) measures,6 which was developed
to evaluate quality of care of patients with acute care
or end-of-life needs admitted to services (e.g., hospice
or hospital admission). It remains unknown how clini-
cians may adhere to this measure in outpatient set-
tings, where needs may be more focused and clinical
interactions may be spread over time. As clinical palli-
ative care continues to grow in noninpatient settings
such as community-based delivery7 and outpatient
clinics,8 the field is beginning to appreciate the differ-
ences in palliative care delivery among varied settings
and the implications for quality measurement.
To better understand the performance of quality
measures across different clinical settings, we exam-
ined MWM measure adherence using a point-of-care
data collection method in a large and diverse patient
population from five Palliative Care Research Cooper-
ative Group (PCRC) member sites.Methods
We conducted a cross-sectional descriptive study of
quality measure implementation across patientsconsulted for specialty palliative care. We included
data entered prospectively into the Quality Data
Collection Tool (QDACT) electronic system by pallia-
tive care clinicians from January 2, 2014, to September
16, 2015. This study was performed within an overall
series of investigations to assess the usability and feasi-
bility of a new QDACT platform for the PCRC. This
investigation was approved by Duke University
(Pro00035703, Pro00055212) and, when applicable,
participating organizations’ institutional review
boards.
Settings
This study was conducted within the PCRC, a multi-
site research infrastructure to support and coordinate
clinical research in palliative care.9 Data collected
from five PCRC organizations were analyzed. Organi-
zations included four academic sites and one
community-based site. Organizations each a priori
devised a sampling technique to identify and collect
data on patients. Investigators worked with their clin-
ical teams to develop a sampling recruitment strategy
to collect data generalizable to the entire practice.10
Data were collected across six common clinical set-
tings of palliative care.
Study Design
We designed this cross-sectional multisite study to
generate descriptive data on adherence to the MWM
measures.4 We compared adherence to quality mea-
sures across six types of palliative care clinical settings:
hospital general floor, hospital intensive care unit
(ICU), emergency department, outpatient, long-term
care, and home. In an additional analysis, all
hospital-based palliative care consultations, including
those from the general floor, ICU, and emergency
department, were aggregated into one category:
‘‘acute care.’’ All others, including outpatient pallia-
tive care clinics, home-based palliative care consulta-
tions, and long-term care facility palliative care visits
were aggregated into ‘‘nonacute care.’’ Palliative care
visits that were coded as ‘‘other’’ were treated as non-
acute care.
Instrument
Clinicians used the QDACT tool to collect near
real-time clinical data across the eight domains of
quality palliative care proposed by the National
Consensus Project for Quality Palliative Care.11 By us-
ing the QDACT, clinicians can report data on up to
82% of all quality measures in the field, including
nine of the MWM measures.1 The QDACT is a
clinician-entered, point-of-care quality assessment
tool that includes commonly used validated clinical
instruments (e.g., Edmonton Symptom Assessment
Vol. 51 No. 3 March 2016 499Implementation of Measuring What MattersSystem,12 Palliative Performance Scale13) when avail-
able and consensus-based clinical assessments linked
to quality measures derived from the QDACT user
panel. Data are entered electronically by clinicians,
research assistants, and support staff through a tablet,
or desktop computer via a Web-based interface by cli-
nicians either during or immediately after a patient
encounter. Completion of these instruments informs
quality measure adherence. For example, if a clinician
enters an Edmonton Symptom Assessment System
pain score of 4, then the system records adherence
to MWM #2 (Screening of Symptoms). The system
uses color-based decision support to alert clinicians
if quality measure adherence is not achieved. Further
details about the QDACT approach14 and the rapid
learning integration of data on quality are covered
elsewhere.15Measures
We evaluated adherence to best practices as repre-
sented in the MWM set across nine of the possible
10 measures (Table 1). As the QDACT is designed as
a clinician-reported instrument, the 10th MWM mea-
sure, patient and family assessments of care, is not
included in the QDACT but was introduced elsewhere
in this JPSM Special Series.16 Although some MWM
measures may specify use in specific palliative care set-
tings (e.g., acute hospitalization >1 day), we applied
the measures to all clinical settings (e.g., outpatient,
long-term care, home, hospital) in which palliative
care was provided during the data collection period.
Denominators for measure assessment were all pa-
tients evaluated by a palliative care specialist and
entered into the QDACT registry during a first clinical
visit. For MWM Measure #9 (Care Consistency with
Documented Care Preferences), this denominator
was limited to patient’s age of 65 years or more. Nu-
merators are described in the following.Definitions of MWM Measure Adherence
For all measures, we evaluated all clinical encoun-
ters entered into the registry. Missing or incorrectly
answered data were counted as not meeting the
measure.
For Measure #1 (Comprehensive Assessment), the
measure was met if there was at least one documented
assessment in the QDACT across each of five domains:
physical, social, psychological, functional, and
spiritual. Additionally, providers had to record an
assessment of family burden, overall well-being, a
one-question spiritual distress screen, performance
status, and at least four symptoms. This definition
was derived from QDACT users through consensus
building before the investigation.For Measures #2 (Screening for Physical Symp-
toms), #3 (Pain Treatment), #4 (Dyspnea Screening
and Management), and #7 (Documentation of Surro-
gate), we used the original measure definitions of nu-
merators and denominators from the measure source
documents without modification.
For Measure #5 (Discussion of Emotional or Psycho-
logical Needs), clinicians met this measure if an anxi-
ety or depression screen had been performed.
For Measure #6 (Discussion of Spiritual/Religious
Concerns), we used a one-question instrument (‘‘Are
you at peace?’’)17 as a proxy for a discussion of spiri-
tual/religious concerns having occurred, which met
criteria for measure adherence.
For Measure #8 (Treatment Preferences), the mea-
sure was met if either resuscitation status or presence
of an advance directive was indicated.
For Measure #9 (Care Consistency with Docu-
mented Care Preferences), we evaluated whether
resuscitation preferences were documented in vulner-
able elders (age >65 years).
Statistical Analysis
We computed descriptive statistics and compared
quality measure adherence between hospital and
nonhospital settings. We used Fisher exact test with
two-tailed P-values for comparison testing.Results
During the study period, we enrolled 2242 patients
into the PCRC QDACT quality registry. Across these
patients, 4893 total encounters were recorded,
including 1989 first visits, 1265 second visits, 643 third
visits, and 385 fourth or later visits. Only first visits
were included for analysis (Table 2). Our population
was mostly white, female, and with moderate perfor-
mance status. About half (52%) of consultations
were seen on hospital general floors.
We observed a wide range of adherence to MWM
measures across the various clinical settings that are
typical to palliative care delivery (Table 1). Excluding
the emergency department because of a small number
of observations, the lowest adherence involved
comprehensive assessments during the first visit for
hospitalized patients in the ICU (2.71%); the highest
adherence across all settings, with an implementation
of >95%, involved documentation of management of
moderate/severe pain. We observed differences in im-
plementation across clinical settings especially with
MWM Measure #2 (Screening for Physical Symptoms;
range 45.7%e81.8%), MWM Measure #5 (Discussion
of Emotional Needs; range 46.1%e96.1%), and
MWM Measure #6 (Documentation of Spiritual/Reli-
gious Concerns; range 0e69.6%). We compared acute
Table 1
Measure Feasibility by Adherence Rate and Location of Consultation
ED
Hospital
General
Floor
Hospital
Intensive
Care Home Long-Term Care Outpatient
All Acute
Care
All Nonacute
Care
P-value on
Acute Care
vs. Non-acute
Care
MWM #1: Palliative care
and hospice patients
receive a comprehensive
assessment (physical,
psychological, social,
spiritual, and functional)
soon after admission
0.00% (0/5) 7.26% (75/1033) 2.71% (7/258) 34.81% (47/135) 22.84% (98/429) 41.09% (53/129) 6.33% (82/1296) 28.75% (198/693) <0.0001
MWM #2: Seriously ill
palliative care and
hospice patients are
screened for pain,
shortness of breath,
nausea, and constipation
during the admission
visit
60.00% (3/5) 56.15% (580/1033) 45.74% (118/258) 81.48% (110/135) 61.54% (264/429) 71.32% (92/129) 54.09% (710/1296) 67.24% (466/693) <0.001
MWM #3: Seriously ill
palliative care and
hospice patients who
screen positive for at
least moderate pain
receive treatment
(medication or other)
within 24 hours
No patients
met
denominator
criteria
98.94% (280/283) 97.30% (36/37) 96.97% (32/33) 100% (90/90) 95.52% (64/67) 98.75% (316/320) 97.89% (186/190) NS
MWM #4: Patients with
advanced or life-
threatening illness are
screened for shortness
of breath and, if positive
to at least a moderate
degree, have a plan
to manage it
No patients
met
denominator
criteria
87.50% (133/152) 91.67% (44/48) 93.75% (30/32) 97.06% (33/34) 75.53% (24/34) 88.50% (177/200) 88.00% (88/100) NS
MWM #5: Seriously ill
palliative care and
hospice patients
have a documented
discussion regarding
emotional needs
60.00% (3/5) 56.82% (587/1033) 46.12% (119/258) 79.26% (107/135) 60.61% (260/429) 96.12% (124/129) 54.71% (709/1296) 70.85% (491/693) <0.0001
MWM #6: Hospice patients
have a documented
discussion of spiritual
concerns or preference
not to discuss them
0.00% (0/5) 18.01% (186/1033) 12.02% (31/258) 69.63% (94/135) 25.26% (156/429) 56.69% (77/129) 16.74% (217/1296) 47.19% (327/693) <0.0001
MWM #7: Seriously ill
palliative care and
hospice patients have
documentation of the
surrogate decision-maker’s
name (such as the person
who has health care power
of attorney) and contact
information, or absence
of a surrogate
100% (5/5) 89.93% (929/1033) 93.41% (241/258) 87.41% (118/135) 89.04% (382/429) 72.87% (94/129) 90.66% (1175/1296) 85.71% (594/693) 0.001
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Table 2
Characteristics of Patients and Consultation Visits
Characteristic
Total patients enrolled 2242
Total n first visits 1989
Gender, n (%)
Female 1228 (55)
Male 961 (43)
Left blank 53 (2)
Race
White 1595 (71)
Black of African American 247 (11)
Asian 36 (2)
American Indian, Alaska Native, Native Hawaiian,
or other Pacific Islander
9 (0.4)
Other 39 (2)
Not reported 316 (16)
Primary diagnosis at first visit
Cancer 607 (31)
Neurologic 405 (20)
Cardiovascular 320 (16)
Pulmonary 219 (11)
Infectious 144 (7)
Other diagnosis 114 (6)
Gastrointestinal 91 (5)
Renal 76 (4)
Unknown 12 (1)
PPS
0e30 484 (24)
40e60 1089 (55)
$70 241 (12)
Unknown 175 (9)
Location of consultation
Hospitaldgeneral floor 1031 (52)
Long-term care 429 (22)
Hospital ICU 258 (13)
Home 135 (7)
Outpatient 129 (6)
Emergency department 5 (0.3)
Other 2 (0.1)
PPS, Palliative Performance Scale; ICU, intensive care unit.
Vol. 51 No. 3 March 2016 501Implementation of Measuring What Mattersand nonacute care settings across six of the nine stud-
ied measures, with a higher implementation rate in
nonacute care settings except for MWM Measure #7
(Documentation of Surrogate), where there was a
higher implementation rate in acute care settings.Discussion
We observed overall high adherence to most MWM
measures, with notable exceptions involving compre-
hensive assessments, documentation of spiritual con-
cerns, and documentation of emotional needs. We
observed significant differences in adherence to six
of the nine MWMmeasures across acute care and non-
acute care locations.
The finding of variable implementation of quality
measures across diverse palliative care clinical settings
is not surprising. For example, the varied implementa-
tion of comprehensive assessments may reflect how cli-
nicians value knowing information across multiple
domains early in the therapeutic relationship. A
502 Vol. 51 No. 3 March 2016Kamal et al.multidomain assessment may not be a priority at the
initial assessment in acute care settings, where more
pressing issues may take precedence. Patients seen for
palliative care consultation in hospital settings are
commonly discharged to systems of care that take a
comprehensive approach, such as home hospice
care.18 Thus, we may be observing inpatient teams
deferring more comprehensive assessments to their
hospice colleagues while focusing their care on limited
reasons for consultation as guided by the referring clini-
cian. This may fall within the concept of ‘‘good consul-
tation etiquette,’’19 which involves trading off
comprehensiveness for meeting the needs of the refer-
ring team. Additionally, inpatient teams may be
focusing their assessments and management on care
not measured by current quality measures, such as
goal setting and discharge planning.20 These teams
may use their valuable and often limited time to address
those issues critical to resolving the acute episode and
then facilitating goals of care evaluations and
discharge. In making this trade-off, hospital clinicians
may be indicating that this specific measure is not the
most feasible, prudent, or efficient way to evaluate the
quality of palliative care delivered in this setting.
This investigation highlights several challenges in
evaluating quality measure feasibility across varied
palliative care clinical settings. One such challenge is
balancing the strict definitions of the numerator and
denominator of a measure with readily available data
within a registry. Clinical teams may need to make
measurement adaptations to fit the data collected.
For example, the PEACE measure of comprehensive
assessment allows up to five days to meet the measure;
our analysis was limited to the first visit. This was a
result of the inherent limitations of our registry,
including significant missingness in some of our
follow-up data that precluded examining longitudinal
changes in measure adherence. Another challenge is
matching care delivered by palliative care teams with
what was documented in QDACT. For this study, it is
not possible to know if lack of adherence to a measure
truly reflects lack of care delivery or failure to docu-
ment. Movements toward a rapid learning health sys-
tem leverages other data inputs like patient-reported
data to complement clinician-entered data and pro-
vide a more comprehensive view of the quality of
care delivered. More sources of data on quality, in
the era of Medicare Access and CHIP Reauthorization
Act legislation, will be needed. Patient-reported qual-
ity of care beyond patient satisfaction is currently
nascent but a rapidly evolving area across all medicine
as patient-reported outcomes measurement becomes
ubiquitous.21
We have a few important limitations to note. First,
we did not collect patient-reported outcomesmeasures. Consequently, we could not evaluate how
care preferences were followed near the end of life
or how patients or families felt about their care (e.g.,
patient or family assessment of quality). We used a
proxy assessment, which was documentation of care
preferences, without truly knowing the extent to
which documented care preferences were followed.
Second, because the registry does not include
patient-reported data, we relied on clinician assess-
ment during data collection to draw conclusions.
The Hawthorne effect (clinicians-modifying behaviors
because of the data collection process) is not measur-
able and likely contributes to some overestimations of
quality measure adherence. Furthermore, clinicians
may have performed a clinical process but not docu-
mented as such; this study evaluates only those that
were documented in the QDACT system. Third, for
this study, we did not test feasibility of this data collec-
tion process. This was performed in a separate study
and will be presented in a subsequent report.Conclusions
Quality measurement in palliative care is a rapidly
evolving area. In response to various national-level
changes in value-based care, including Medicare Ac-
cess and CHIP Reauthorization Act legislation, pallia-
tive care practices will be more responsible than ever
to collect, report, and respond to data on quality. Inte-
grating data collection practices for measuring quality
into usual care delivery will be essential to reduce
downstream burden on clinicians from retrospective
data abstraction while also empowering clinicians to
improve quality simultaneous to care delivery. Data
will need to be actionable by busy clinicians near point
of care and lead to meaningful changes in palliative
care delivery that respond to the unique environments
and stressors of serious illness care. The feasibility of
such efforts will need to be closely studied. Such
studies will add to our understanding of how this
can best occur within the complex and busy environ-
ments of palliative care delivery.Disclosures and Acknowledgments
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